Skip to main content
Watch Insiders
ETON filings

Corporate insider profile

David Krempa Filing Activity

Latest reported as Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON).

Purchase filings
0
Reported companies
1
Net open-market value
-$5,086,076.21
Latest transaction
Oct 6, 2026

Affiliated corporations

Reported company relationships

ETONLatest reported

Eton Pharmaceuticals, Inc.

Chief Business Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 6, 2026Eton Pharmaceuticals, Inc. (ETON)Chief Business OfficerSale4,166$55.07$229,406
Aug 24, 2026Eton Pharmaceuticals, Inc. (ETON)Chief Business OfficerSale25,000$65.07$1,626,750
May 27, 2026Eton Pharmaceuticals, Inc. (ETON)Chief Business OfficerSale100,000$32.30$3,229,920